Diseases
A new collaboration between charities Cure Parkinson's and Alzheimer's Research UK is underway to explore the potential of existing drugs to treat both Alzheimer's disease and Parkinson's. This approach, known as repurposing drugs, aims to swiftly discover new treatments by identifying common
Diseases
Scientists from the fields of Alzheimer's and Parkinson's disease research are joining forces to explore the possibility of repurposing existing drugs to treat both conditions. This innovative approach seeks to leverage the knowledge and experience gained from the International Linked Clinical Trials (iLCT) project, which has
Diseases
A team of researchers from China Pharmaceutical University has developed a novel approach to predicting effective drug-target interactions using a multimodal transformer graph neural network. This innovative framework, known as MTGNN, models the complex directional dependencies and synergistic mechanisms underlying tripartite drug-target-disease (GTD) interactions. By integrating topological structure and semantic
Cancer patients
Kevin Wemyss, a 47-year-old data network engineer from Inverness, was told he had a rare and aggressive form of liver cancer, cholangiocarcinoma, by a Scottish NHS nurse before the biopsy was even confirmed. The nurse informed him that there were limited treatment options available, despite new targeted drugs being approved
Trump, Donald
The UK government has agreed to restrict the use of Chinese-made chemicals and components in medicines bound for the US, following pressure from US President Donald Trump. The move is part of the landmark UK-US trade pact aimed at securing national security measures. Despite the UK's heavy dependence
Drugs
Donald Trump's latest executive order aims to reduce prescription drug prices in the US, but experts say it will not accomplish much. The order directs the HHS Secretary to come up with a plan to determine "most-favored-nation price targets" for pharmaceutical companies, but this is a
Trump, Donald
President Donald Trump has threatened European countries that they must pay higher drug prices or face trade sanctions, while vowing to cut US drug prices by as much as 80 per cent. Speaking at the White House, Trump stated his administration would punish countries that refuse to "equalise"
Americans
President Donald Trump declared that the U.S. would no longer tolerate "profiteering and price gouging from Big Pharma" as he signed an executive order implementing the "most favored nations" drug pricing policy. The policy sets a price ceiling for prescription drugs in the U.S.
Drugs
US President Donald Trump's executive order on "Most Favored Nation" (MFN) drug pricing aims to align US drug prices with those paid in other developed countries. The order requires the Department of Health and Human Services (HHS) to set target drug prices within 30 days, with
Drugs
Donald Trump signed an executive order yesterday, directing drug makers to lower the prices of their medicines to align with what other countries pay. The order, which gives companies 30 days to cut the cost of prescription drugs in the US or face new limits on what the government will
Drugs
President Donald Trump signed an executive order aimed at pressuring pharmaceutical companies to align their U.S. pricing models with those in similarly wealthy countries. The "most-favored-nation" policy gives pharmaceutical companies 30 days to negotiate lower drug prices with the government. If no deal is reached, the US
Drugs
US President Donald Trump has vowed to drastically reduce pharmaceutical prices in the United States by implementing a "Most Favoured Nation" policy, where the cost of prescription drugs sold in the US would be pegged to the lowest price paid by other countries for the same drug. Trump
